Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants

Clinical trial NCT03605654 · WITHDRAWN

Trial details

NCT number: NCT03605654
Sponsor: Medeor Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Kidney Transplant Rejection

Start date: 2024-12-01
Primary completion: 2026-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.